本页面由Tiger Trade Technology Pte. Ltd.提供服务

爵士制药

217.30
-1.1200-0.51%
成交量:47.31万
成交额:1.04亿
市值:141.06亿
市盈率:14.85
高:221.99
开:218.90
低:216.87
收:218.42
52周最高:266.38
52周最低:128.80
股本:6,491.46万
流通股本:6,269.43万
量比:0.52
换手率:0.75%
股息:- -
股息率:- -
每股收益(TTM):14.63
每股收益(LYR):-5.8403
净资产收益率:22.11%
总资产收益率:6.86%
市净率:2.94
市盈率(LYR):-37.21

数据加载中...

2026/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/24

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/24

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities